Navigation Links
Wyeth Declares Common and Preferred Stock Dividends

MADISON, N.J., June 26 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE) declared dividends on both the Common and Preferred Stock of the Company.

A dividend of twenty-eight cents ($.28) per share on the outstanding shares of Common Stock was declared payable on September 2, 2008 to stockholders of record at the close of business on August 13, 2008.

In addition, a dividend of fifty cents ($.50) per share on the outstanding shares of Preferred Stock was declared payable on October 1, 2008 to stockholders of record at the close of business on September 12, 2008.

Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
3. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
4. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
5. Wyeth Chairman Robert Essner Announces June 27 Retirement
6. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
7. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
9. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
10. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
11. Wyeth Announces Executive Change in Finance Organization
Post Your Comments:
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
Breaking Biology Technology:
(Date:11/19/2015)...  Based on its in-depth analysis of the biometric ... the 2015 Global Frost & Sullivan Award for Product ... this award to the company that has developed the ... the market it serves. The award recognizes the extent ... customer base demands, the overall impact it has in ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
Breaking Biology News(10 mins):